Immuneering (IMRX) Current Leases (2020 - 2026)
Immuneering's (IMRX) quarterly Current Leases came in at $412835.0 in Q1 2026, up 17.11% year-on-year from $352521.0 in Q1 2025, and up 3.96% quarter-over-quarter from $397104.0 in Q4 2025.
Immuneering (IMRX) Current Leases (2020 - 2026) Analysis & Trends
Immuneering's Current Leases history runs 7 years deep, the most recent figure standing at $412835.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 17.11% year-over-year to $412835.0 in Q1 2026; TTM through Mar 2026 was $412835.0, a 17.11% increase from a year earlier, with the FY2025 full-year figure at $397104.0, up 17.33% from the prior year.
- Current Leases climbed to $412835.0 in Q1 2026 per IMRX's latest filing, from $397104.0 in the prior quarter.
- Across five years, Current Leases topped out at $412835.0 in Q1 2026 and bottomed at $265419.0 in Q1 2022.
- The 5-year median for Current Leases is $332675.0 (2023), against an average of $336540.2.
- Across the five-year window, Current Leases surged 272.84% in 2022 and retreated 20.76% in 2023, its largest moves.
- Year by year, Current Leases stood at $378723.0 in 2022, then slipped by 20.76% to $300107.0 in 2023, then advanced by 12.77% to $338438.0 in 2024, then advanced by 17.33% to $397104.0 in 2025, then climbed by 3.96% to $412835.0 in 2026.
- Per Business Quant, the three latest IMRX Current Leases figures stand at $412835.0 (Q1 2026), $397104.0 (Q4 2025), and $381760.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Immuneering | 283.85 Mn | 283.85 Mn | - | 412,835.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 412,835.00 |
| Dec 31, 2025 | 397,104.00 |
| Sep 30, 2025 | 381,760.00 |
| Jun 30, 2025 | 366,959.00 |
| Mar 31, 2025 | 352,521.00 |
| Dec 31, 2024 | 338,438.00 |
| Sep 30, 2024 | 324,702.00 |
| Jun 30, 2024 | 311,459.00 |
| Mar 31, 2024 | 298,543.00 |
| Dec 31, 2023 | 300,107.00 |
| Sep 30, 2023 | 301,633.00 |
| Jun 30, 2023 | 332,675.00 |
| Mar 31, 2023 | 363,238.00 |
| Dec 31, 2022 | 378,723.00 |
| Sep 30, 2022 | 308,694.00 |
| Jun 30, 2022 | 286,374.00 |
| Mar 31, 2022 | 265,419.00 |
| Dec 31, 2021 | 274,039.00 |
| Sep 30, 2021 | 82,795.00 |
| Jun 30, 2021 | 80,605.00 |